Exelixis, Inc. SEC filings EXEL
Exelixis, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Mar 2, 2018. Its latest annual report, Form 10-K, was filed on Feb 10, 2026 for the period ended Jan 2, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Oct 2, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on January 1.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Oct 2, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jul 3, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Apr 3, 2026 |
| 10-Q | Quarterly report | Nov 4, 2025 | Oct 3, 2025 |
| 10-Q | Quarterly report | Jul 28, 2025 | Jul 4, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Apr 4, 2025 |
| 10-Q | Quarterly report | Oct 29, 2024 | Sep 27, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 28, 2024 |
| 10-Q | Quarterly report | Apr 30, 2024 | Mar 29, 2024 |
| 10-Q | Quarterly report | Nov 1, 2023 | Sep 29, 2023 |
| 10-Q | Quarterly report | Aug 1, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 1, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jul 1, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Apr 1, 2022 |
| 10-Q | Quarterly report | Nov 2, 2021 | Oct 1, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jul 2, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Apr 2, 2021 |
| 10-Q | Quarterly report | Nov 5, 2020 | Oct 2, 2020 |
| 10-Q | Quarterly report | Aug 6, 2020 | Jul 3, 2020 |
| 10-Q | Quarterly report | May 5, 2020 | Apr 3, 2020 |
| 10-Q | Quarterly report | Oct 30, 2019 | Sep 27, 2019 |
| 10-Q | Quarterly report | Jul 31, 2019 | Jun 28, 2019 |
| 10-Q | Quarterly report | May 1, 2019 | Mar 29, 2019 |
| 10-Q | Quarterly report | Nov 1, 2018 | Sep 28, 2018 |
| 10-Q | Quarterly report | Aug 1, 2018 | Jun 29, 2018 |
| 10-Q | Quarterly report | May 2, 2018 | Mar 30, 2018 |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- EXEL (Nasdaq)
- Fiscal year ends
- January 1
- Incorporated in
- DE
- Headquarters
- Alameda, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 939767
- Former names
- EXELIXIS INC (until Sep 12, 2012)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.